BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 1313164)

  • 1. Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication.
    Balster RL; Prescott WR
    Neurosci Biobehav Rev; 1992; 16(1):55-62. PubMed ID: 1313164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys.
    Wiley JL; Huffman JW; Balster RL; Martin BR
    Drug Alcohol Depend; 1995 Nov; 40(1):81-6. PubMed ID: 8746928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Δ
    Gatch MB; Forster MJ
    Psychopharmacology (Berl); 2018 Mar; 235(3):673-680. PubMed ID: 29138877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.
    Hiltunen AJ; Järbe TU
    Eur J Pharmacol; 1986 Jun; 125(2):301-4. PubMed ID: 3017729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of delta 9-tetrahydrocannabinol and delta 9-11-tetrahydrocannabinol in rats and rhesus monkeys.
    Wiley JL; Barrett RL; Britt DT; Balster RL; Martin BR
    Neuropharmacology; 1993 Apr; 32(4):359-65. PubMed ID: 8388551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Δ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats.
    Gatch MB; Forster MJ
    Psychopharmacology (Berl); 2016 May; 233(10):1901-10. PubMed ID: 26875756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis: discrimination of "internal bliss"?
    Wiley JL
    Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological potency of R- and S-3'-hydroxy-delta 9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity.
    Martin BR; Kallman MJ; Kaempf GF; Harris LS; Dewey WL; Razdan RK
    Pharmacol Biochem Behav; 1984 Jul; 21(1):61-5. PubMed ID: 6087379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus- and open-field effects of the enantiomers of 11-hydroxy-delta-8-tetrahydrocannabinol in pigeons and gerbils.
    Järbe TU; Mechoulam R; Zahalka J
    Pharmacol Biochem Behav; 1994 Jan; 47(1):113-9. PubMed ID: 8115412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalization of the discriminative stimulus properties of delta 9-THC to delta 9(11)-THC in rats.
    Semjonow A; Binder M
    Psychopharmacology (Berl); 1985; 85(2):178-83. PubMed ID: 2989965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.
    Wiley JL; Marusich JA; Blough BE; Namjoshi O; Brackeen M; Akinfiresoye LR; Walker TD; Prioleau C; Barrus DG; Gamage TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jun; 132():110984. PubMed ID: 38417478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure.
    Burkey RT; Nation JR
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):195-202. PubMed ID: 9260067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.
    Wiley JL; Lefever TW; Cortes RA; Marusich JA
    Pharmacol Biochem Behav; 2014 Sep; 124():123-8. PubMed ID: 24887450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the discriminative stimulus and response rate effects of
    Wiley JL; Lefever TW; Marusich JA; Craft RM
    Drug Alcohol Depend; 2017 Mar; 172():51-59. PubMed ID: 28130989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201.
    AlKhelb D; Burke EL; Zvonok A; Iliopoulos-Tsoutsouvas C; Georgiadis MO; Jiang S; Ho TC; Nikas SP; Makriyannis A; Desai RI
    Eur J Pharmacol; 2023 Dec; 960():176168. PubMed ID: 38059442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
    Lile JA; Kelly TH; Hays LR
    Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug discrimination properties and cytotoxicity of the cannabinoid receptor ligands].
    Tomiyama K; Funada M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Jun; 47(3):135-43. PubMed ID: 22894054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats.
    Wiley JL; Barrett RL; Lowe J; Balster RL; Martin BR
    Neuropharmacology; 1995 Jun; 34(6):669-76. PubMed ID: 7566504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys.
    McMahon LR
    Drug Alcohol Depend; 2016 Aug; 165():87-93. PubMed ID: 27289270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.